N-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide

C38H38F5N9O5 — CID 176641260

IUPACN-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide
SMILESCOc1cc(NC(=O)c2cncc(C(F)(F)F)n2)cc2cn(C3CCC(CN4CC[C@@H](c5cccc6c5[nH]c(=O)n6C5CCC(=O)NC5=O)C(F)(F)C4)CC3)nc12
InChIInChI=1S/C38H38F5N9O5/c1-57-29-14-22(45-34(54)26-15-44-16-30(46-26)38(41,42)43)13-21-18-51(49-32(21)29)23-7-5-20(6-8-23)17-50-12-11-25(37(39,40)19-50)24-3-2-4-27-33(24)48-36(56)52(27)28-9-10-31(53)47-35(28)55/h2-4,13-16,18,20,23,25,28H,5-12,17,19H2,1H3,(H,45,54)(H,48,56)(H,47,53,55)/t20?,23?,25-,28?/m0/s1
InChIKeyNMWGEVKEQNSVPC-PFZORWLESA-N
MW795.77 g/mol
LogP5.58
Rot. Bonds8

About N-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide

N-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide (PubChem CID 176641260) has the molecular formula C38H38F5N9O5 and a molecular weight of 795.77 g/mol. Its IUPAC name is N-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide.

Molecular Properties

Compound NameN-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide
PubChem CID176641260
Molecular FormulaC38H38F5N9O5
Molecular Weight795.77 g/mol
Exact Mass795.29
IUPAC NameN-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide
SMILESCOc1cc(NC(=O)c2cncc(C(F)(F)F)n2)cc2cn(C3CCC(CN4CC[C@@H](c5cccc6c5[nH]c(=O)n6C5CCC(=O)NC5=O)C(F)(F)C4)CC3)nc12
InChIInChI=1S/C38H38F5N9O5/c1-57-29-14-22(45-34(54)26-15-44-16-30(46-26)38(41,42)43)13-21-18-51(49-32(21)29)23-7-5-20(6-8-23)17-50-12-11-25(37(39,40)19-50)24-3-2-4-27-33(24)48-36(56)52(27)28-9-10-31(53)47-35(28)55/h2-4,13-16,18,20,23,25,28H,5-12,17,19H2,1H3,(H,45,54)(H,48,56)(H,47,53,55)/t20?,23?,25-,28?/m0/s1
InChIKeyNMWGEVKEQNSVPC-PFZORWLESA-N
XLogP5.58
TPSA169.13 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds8
Heavy Atoms57
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500795.77
LogP ≤ 55.58
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide?
The IUPAC name of N-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide (CID 176641260) is N-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide.
What is the SMILES notation for N-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide?
The canonical SMILES for N-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide is COc1cc(NC(=O)c2cncc(C(F)(F)F)n2)cc2cn(C3CCC(CN4CC[C@@H](c5cccc6c5[nH]c(=O)n6C5CCC(=O)NC5=O)C(F)(F)C4)CC3)nc12.
What is the InChIKey of N-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide?
The InChIKey is NMWGEVKEQNSVPC-PFZORWLESA-N. The full InChI is InChI=1S/C38H38F5N9O5/c1-57-29-14-22(45-34(54)26-15-44-16-30(46-26)38(41,42)43)13-21-18-51(49-32(21)29)23-7-5-20(6-8-23)17-50-12-11-25(37(39,40)19-50)24-3-2-4-27-33(24)48-36(56)52(27)28-9-10-31(53)47-35(28)55/h2-4,13-16,18,20,23,25,28H,5-12,17,19H2,1H3,(H,45,54)(H,48,56)(H,47,53,55)/t20?,23?,25-,28?/m0/s1.
What are the key properties of N-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide?
N-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide has a molecular weight of 795.77 g/mol, XLogP of 5.58, 8 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-[[(4S)-4-[1-(2,6-dioxopiperidin-3-yl)-2-oxo-3H-benzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]-7-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide is sourced from PubChem (CID 176641260), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).